Download PDF
Aktuelle Rheumatologie 2011; 36(06): 372-377
DOI: 10.1055/s-0031-1284402
Übersichtsarbeit
© Georg Thieme Verlag KG Stuttgart · New York

Gender-Aspekte beim Systemischen Lupus erythematodes

Gender Aspects in Systemic Lupus Erythematosus
R. Fischer-Betz
1   Heinrich-Heine-Universität Düsseldorf, Klinik für Endokrinologie, Diabetologie und Rheumatologie, Düsseldorf
,
W. Dohrn
1   Heinrich-Heine-Universität Düsseldorf, Klinik für Endokrinologie, Diabetologie und Rheumatologie, Düsseldorf
,
G. Chehab
1   Heinrich-Heine-Universität Düsseldorf, Klinik für Endokrinologie, Diabetologie und Rheumatologie, Düsseldorf
› Author Affiliations
Further Information

Publication History

Publication Date:
28 November 2011 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Inzidenz von Autoimmunerkrankungen wird wesentlich durch das Geschlecht beeinflusst. Der Systemische Lupus erythematosus (SLE) betrifft weitaus mehr Frauen als Männer, allerdings ist die Ursache hierfür nicht genau bekannt. Zudem gibt es viele kontroverse Aussagen in Bezug auf Unterschiede in den klinischen Manifestationen bei beiden Geschlechtern. Männer mit SLE haben insgesamt das gleiche Spektrum an Krankheitsausprägungen wie Frauen. Ein Raynaud-Syndrom und eine Arthritis sind möglicherweise bei Frauen häufiger, eine Serositis und Nierenbeteiligung bei Männern. Frauen scheinen häufiger Schübe zu entwickeln, die Inzidenz von schweren Schüben unterscheidet sich aber bei den Geschlechtern nicht. Ursachen der weiblichen Bevorzugung sind neben hormonellen Unterschieden sehr wahrscheinlich auch weitere, z. B. X-chromosomal abhängige genetische Faktoren.

Abstract

Gender plays a profound role in the incidence of autoimmune diseases. Systemic lupus erythematosus (SLE) is known to be much more prevalent in females than in males, but the cause of this sexual predilection has not been established. In addition, much controversy surrounds the differences in manifestations of SLE in both sexes. Male SLE has the same disease spectrum as female SLE. Raynaud phenomenon and arthritis seem to be more common in women and serositis and renal involvement in men. Clinical manifestations of SLE include the facts that females have more frequent relapses, but the incidence of severe relapses is the same in both sexes. Potential causes of the female predilection for SLE include hormonal influences and X-chromosomal dependent genetic factors.

Schlüsselwörter

systemischer Lupus erythematodes - gender - Morbidität - Prognose

Key words

systemic lupus erythematosus - gender - morbidity - prognosis
 

  • Literatur

  • 1 Rus V, Maury EE, Hochberg MC. The epidemiology of systemic lupus erythematosus. In: Duboisʼ Lupus Erythematosus. Wallace DJ, Hahn BH. (eds.) Lippincott Williams and Wilkins; Philadelphia: 2002
    Search in Google Scholar
  • 2 Symmons DP. Frequency of lupus in people of African origin. Lupus 1995; 4: 176-178
    CrossrefPubMedSearch in Google Scholar
  • 3 Somers EC, Thomas SL, Smeeth L et al. Incidence of systemic lupus erythematosus in the United Kingdom, 1990–1999. Arthritis Rheum 2007; 57: 612-618
    CrossrefPubMedSearch in Google Scholar
  • 4 López P, Mozo L, Gutiérrez C et al. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003; 12 (11) 860-865
    CrossrefPubMedSearch in Google Scholar
  • 5 Cervera R, Khamashta MA, Font J et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72 (02) 113-124
    PubMedSearch in Google Scholar
  • 6 Garcia MA, Marcos JC, Marcos AI et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1 214 patients. Lupus 2005; 14 (12) 938-946
    CrossrefPubMedSearch in Google Scholar
  • 7 Voulgari PV, Katsimbri P, Alamanos Y et al. Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature. Lupus 2002; 11 (11) 722-729
    CrossrefPubMedSearch in Google Scholar
  • 8 Feng JB, Ni JD, Yao X et al. Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases. Rheumatol Int. 2010; Jun 30 (08) 1017-1023
    PubMedSearch in Google Scholar
  • 9 McCarty DJ, Manzi S, Medsger TA et al. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995; 38: 1260-1270
    CrossrefPubMedSearch in Google Scholar
  • 10 Andrade RM, Alarcón GS, Fernández M et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum 2007; 56 (02) 622-630
    CrossrefPubMedSearch in Google Scholar
  • 11 Molina JF, Drenkard C, Molina J et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore) 1996; 75 (03) 124-130
    CrossrefPubMedSearch in Google Scholar
  • 12 Ackerman LS. Sex hormones and the genesis of autoimmunity. Arch Dermatol 2006; 142: 371-376
    CrossrefPubMedSearch in Google Scholar
  • 13 Beagley KW, Gockel CM. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003; 38: 13-22
    CrossrefPubMedSearch in Google Scholar
  • 14 Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11: 352-356
    CrossrefPubMedSearch in Google Scholar
  • 15 Costenbader KH, Feskanich D, Stampfer MJ et al. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 2007; 56: 1251-1262
    CrossrefPubMedSearch in Google Scholar
  • 16 Folomeev M, Dougados M, Beaune J et al. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1992; 1 (03) 191-195
    CrossrefPubMedSearch in Google Scholar
  • 17 McMurray RW, May W. Sex hormones an systemic lupus erythematosus. Arthritis Rheum 2003; 48 (08) 2100-2110
    CrossrefPubMedSearch in Google Scholar
  • 18 Buyon JP, Petri MA, Kim MY et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005; 21 142 953-962
    PubMedSearch in Google Scholar
  • 19 Petri M, Kim MY, Kalunian KC et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353 (24) 2550-2558
    CrossrefPubMedSearch in Google Scholar
  • 20 Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol 2011; 40 (01) 42-49
    CrossrefPubMedSearch in Google Scholar
  • 21 Scofield RH, Bruner GR, Namjou B et al. Klinefelter’s syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008; 58 (08) 2511-2517
    CrossrefPubMedSearch in Google Scholar
  • 22 Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989; May 68 (03) 141-150
    PubMedSearch in Google Scholar
  • 23 Mok CC, Lau CS, Chan TM et al. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 1999; 8 (03) 188-196
    CrossrefPubMedSearch in Google Scholar
  • 24 Pande I, Malaviya AN, Sekharan NG et al. SLE in Indian men: analysis of the clinical and laboratory features with a review of the literature. Lupus 1994; 3 (03) 181-186
    CrossrefPubMedSearch in Google Scholar
  • 25 Specker C, Becker A, Lakomek HJ et al. Systemic lupus erythematosus in men–a different prognosis?. Z Rheumatol 1994; 53 (06) 339-345
    PubMedSearch in Google Scholar
  • 26 Carbone LD, Lohr KM. Ethnic differences in male lupus. J Clin Rheumatol 2002; 8 (04) 239-240
    CrossrefPubMedSearch in Google Scholar
  • 27 Koh WH, Fong KY, Boey ML et al. Systemic lupus erythematosus in 61 Oriental males. A study of clinical and laboratory manifestations. Br J Rheumatol 1994; 33 (04) 339-342
    CrossrefPubMedSearch in Google Scholar
  • 28 Camilleri F, Mallia C. Male SLE patients in Malta. Adv Exp Med Biol 1999; 455: 173-179
    PubMedSearch in Google Scholar
  • 29 Hochberg MC, Boyd RE, Ahearn JM et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985; 64 (05) 285-295
    PubMedSearch in Google Scholar
  • 30 Ward MM, Studenski S. Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990; 17 (02) 220-224
    PubMedSearch in Google Scholar
  • 31 Soto ME, Vallejo M, Guillén F et al. Gender impact in systemic lupus erythematosus. Clin Exp Rheumatol 2004; 22 (06) 713-721
    PubMedSearch in Google Scholar
  • 32 Aranow C, Del Guidice J, Barland P et al. Systemic lupus erythematosus disease severity in men and women: a case-control study. J Rheumatol 2002; 29 (08) 1674-1677
    PubMedSearch in Google Scholar
  • 33 Font J, Cervera R, Navarro M et al. Systemic lupus erythematosus in men: clinical and immunological characteristics. Ann Rheum Dis 1992; 51 (09) 1050-1052
    CrossrefPubMedSearch in Google Scholar
  • 34 Medina G, Vera-Lastra O, Barile L et al. Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients. Lupus 2004; 13 (01) 11-16
    CrossrefPubMedSearch in Google Scholar
  • 35 Chang DM, Chang CC, Kuo SY et al. The clinical features and prognosis of male lupus in Taiwan. Lupus 1998; 7 (07) 462-468
    CrossrefPubMedSearch in Google Scholar
  • 36 Cervera R, Khamashta MA, Hughes GR. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus 2009; 18 (10) 869-874
    CrossrefPubMedSearch in Google Scholar
  • 37 Rabbani MA, Ahmad B, Shah SM et al. Clinico-laboratory findings in male lupus patients from a tertiary care hospital, Pakistan. J Pak Med Assoc 2005; 55 (04) 165-166
    PubMedSearch in Google Scholar
  • 38 Chung SA, Tian C, Taylor KE et al. European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus. Arthritis Rheum 2009; 60: 2448-2456
    CrossrefPubMedSearch in Google Scholar
  • 39 Bernatsky S, Peschken C, Fortin PR et al. Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS). Medication use in systemic lupus erythematosus. J Rheumatol 2011; 38 (02) 271-274
    CrossrefPubMedSearch in Google Scholar
  • 40 Bernatsky S, Boivin JF, Joseph L et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54 (08) 2550-2557
    CrossrefPubMedSearch in Google Scholar
  • 41 Fischer-Betz R, Wessel E, Richter J et al. Lupus in Germany: analysis within the German lupus self-help organization (LULA). Z Rheumatol 2005; 64 (02) 111-122
    CrossrefPubMedSearch in Google Scholar
  • 42 Sander O, Wessel E, Richter J et al. Disability in lupus erythematosus. Versicherungsmedizin 2006; 58 (03) 120-125
    PubMedSearch in Google Scholar
  • 43 Zink A, Fischer-Betz R, Thiele K et al. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres. Lupus 2004; 13 (07) 529-536
    CrossrefPubMedSearch in Google Scholar
  • 44 Wallace DJ, Podell T, Weiner J et al. Systemic lupus erythematosus – survival patterns. Experience with 609 patients. JAMA 1981; 245 (09) 934-938
    CrossrefPubMedSearch in Google Scholar
  • 45 Swaak AJ, Nossent JC, Bronsveld W et al. Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989; 48 (06) 447-454
    CrossrefPubMedSearch in Google Scholar
  • 46 Manger K, Manger B, Repp R et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 2002; 61: 1065-1070
    CrossrefPubMedSearch in Google Scholar
  • 47 Pistiner M, Wallace DJ, Nessim S et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991; 21 (01) 55-64
    CrossrefPubMedSearch in Google Scholar
  • 48 Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990; 33 (01) 37-48
    CrossrefPubMedSearch in Google Scholar